RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 The ASTIS Trial: First Results
JF MD Conference Express
YR 2012
FD SAGE Publications
VO 12
IS 9
SP 8
OP 8
DO 10.1177/155989771209004
UL http://mdc.sagepub.com/content/12/9/8.1.abstract
AB This article discusses the first results from the Autologous Stem Cell Transplantation International Scleroderma trial [ASTIS; ISRCTN54371254], an international, investigator-initiated, open-label Phase 3 trial that suggests that hematopoietic stem cell transplantation results in better long-term event-free and overall survival compared with conventional treatment for patients with poor prognosis, early diffuse, cutaneous systemic sclerosis.